In 2002 colorectal cancer will be diagnosed in 148,300 men and women and cause 56,600 deaths, account for 785,000 life years lost, and cost this country 6 billion dollars. Colonoscopy is increasingly being used as a screening option even though there is uncertainty as to the benefit and harms of this approach in comparison to FOBT. A recent study of V.A. men showed that a single colonoscopy may be a better option than FOBT because of its detection of advanced adenomas as well as early stage cancers. This approach has not been studied in 'general population' men and women and has not been compared directly to a program of annual FOBT. The long-term objective of this proposal is to compare a single screening colonoscopy directly to programmatic FOBT in general population men and women. The study in progress demonstrated a lower rate (6%) of advanced neoplasia (advanced adenoma or early cancer) detected by screening colonoscopy as compared to the V.A. Trial (10.5%). This raised the question of how much better a single screening colonoscopy is than an FOBT directed colonoscopy. We therefore designed a trial to compare the benefits and harms of the two strategies. Participation in a single colonoscopy may be higher than with a program of annual FOBT. However, the number of colonoscopies needed to detect advanced neoplasia also may be greater than with FOBT directed colonoscopy. The trial will involve three clinical centers, a Pathology Review Center, and a Coordinating Center. The organization of this study will build on the ongoing randomized trial of screening colonoscopy vs. usual care, using the same infrastructure and accumulating colonoscopy data from the proposed study and the present study. This data will be used as a basis for calculating in the general population the benefits, harms, and medical resource burden of potentially the most effective screening test (colonoscopy) as compared to the most commonly used screening test (FOBT). The results of this study will have major implications in prioritizing national guidelines and in clarifying financial and clinical resources and manpower issues.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA079572-08
Application #
7247971
Study Section
Subcommittee G - Education (NCI)
Program Officer
Umar, Asad
Project Start
1999-09-01
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
8
Fiscal Year
2007
Total Cost
$1,028,011
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Mendelsohn, Robin B; Winawer, Sidney J; Jammula, Anjani et al. (2017) Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening Colonoscopy: The National Colonoscopy Study. Clin Gastroenterol Hepatol 15:1469-1470
Zauber, Ann G (2015) The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci 60:681-91
Shaukat, Aasma; Church, Timothy R; Shanley, Ryan et al. (2015) Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy. Cancer Epidemiol Biomarkers Prev 24:913-20
Zauber, Ann G; Winawer, Sidney J; O'Brien, Michael J et al. (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366:687-96